Clinical Trials Browser

Advanced Solid Tumors × tislelizumab × 90 days × Clear all

NCT06596473 2026-06-04

A Study of BG-C477 in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumors